Update on diagnosis and management of neoplastic pericardial disease

被引:9
作者
Avondo, Stefano [1 ]
Andreis, Alessandro [1 ]
Casula, Matteo [1 ]
Imazio, Massimo [1 ]
机构
[1] AOU Citta Salute & Sci Torino, Cardiovasc & Thorac Dept, Univ Cardiol, Turin, Italy
关键词
Pericardium; mass; tumor; neoplastic; effusion; ENDOTHELIAL GROWTH-FACTOR; MALIGNANT MESOTHELIOMA; EUROPEAN ASSOCIATION; PLEURAL EFFUSION; CARDIAC TUMORS; RADIOTHERAPY; PHARMACOKINETICS; CHEMOTHERAPY; BIOMARKERS; CYFRA-21-1;
D O I
10.1080/14779072.2020.1811087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Pericardial neoplasms are uncommon, mostly due to secondary involvement of the pericardium by extracardiac tumors. Clinical presentation is nonspecific, frequently leading to a delayed diagnosis. Moreover, both benign and malignant pericardial tumors may be associated with myocardial infiltration and mechanical compression of cardiac chambers, possibly precipitating clinical conditions. Pericardial tumors are indeed a diagnostic and therapeutic clinical challenge. Areas covered: This review aims to provide an overview of the main clinical characteristics of pericardial tumors, along with their management in clinical practice. Expert commentary: Multimodality imaging (echocardiography, chest X-ray, CT, CMR, and PET) enable full characterization of pericardial neoplasms. An individualized strategy should be developed by a multidisciplinary team including cardiologists, oncologists, radiologists, and cardiac surgeons.
引用
收藏
页码:615 / 623
页数:9
相关论文
共 73 条
[11]  
Buyukbayrak Fuat, 2014, Asian Cardiovasc Thorac Ann, V22, P296, DOI 10.1177/0218492313484317
[12]  
CASPER ES, 1983, CANCER TREAT REP, V67, P235
[13]   Systemic chemotherapy in combination with pericardial window has better outcomes in malignant pericardial effusions [J].
Celik, Sezai ;
Lestuzzi, Chiara ;
Cervesato, Eugenio ;
Dequanter, Didier ;
Piotti, Patrizia ;
De Biasio, Marzia ;
Imazio, Massimo .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05) :2288-2293
[14]   Multimodality Imaging for the Assessment of Pericardial Diseases [J].
Chetrit, Michael ;
Xu, Bo ;
Verma, Beni R. ;
Klein, Allan L. .
CURRENT CARDIOLOGY REPORTS, 2019, 21 (05)
[15]   European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease [J].
Cosyns, Bernard ;
Plein, Sven ;
Nihoyanopoulos, Petros ;
Smiseth, Otto ;
Achenbach, Stephan ;
Andrade, Maria Joao ;
Pepi, Mauro ;
Ristic, Arsen ;
Imazio, Massimo ;
Paelinck, Bernard ;
Lancellotti, Patrizio .
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2015, 16 (01) :12-U162
[16]   Treatment of malignant pericardial effusion with 32P-colloid [J].
Dempke, W ;
Firusian, N .
BRITISH JOURNAL OF CANCER, 1999, 80 (12) :1955-1957
[17]  
Fagaly RL, 1995, SOFE '95 - 16TH IEEE/NPSS SYMPOSIUM ON FUSION ENGINEERING, VOLS 1 AND 2, P26, DOI 10.1109/FUSION.1995.534167
[18]   PHARMACOKINETICS OF VM-26 GIVEN INTRAPERICARDIALLY OR INTRAVENOUSLY IN PATIENTS WITH MALIGNANT PERICARDIAL-EFFUSION [J].
FIGOLI, F ;
ZANETTE, ML ;
TIRELLI, U ;
SORIO, R ;
LESTUZZI, C ;
URSO, R ;
MONFARDINI, S ;
DINCALCI, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) :239-242
[19]   CARDIAC TUMORS - ASSESSMENT WITH GD-DTPA ENHANCED MR IMAGING [J].
FUNARI, M ;
FUJITA, N ;
PECK, WW ;
HIGGINS, CB .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (06) :953-958
[20]  
GAVIN FM, 1988, ACTA CYTOL, V32, P175